Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 4
2020 6
2021 10
2022 6
2023 4
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Blood biomarkers of neurodegeneration associate differently with amyloid deposition, medial temporal atrophy, and cerebrovascular changes in APOE ε4-enriched cognitively unimpaired elderly.
Koivumäki M, Ekblad L, Lantero-Rodriguez J, Ashton NJ, Karikari TK, Helin S, Parkkola R, Lötjönen J, Zetterberg H, Blennow K, Rinne JO, Snellman A. Koivumäki M, et al. Alzheimers Res Ther. 2024 May 18;16(1):112. doi: 10.1186/s13195-024-01477-w. Alzheimers Res Ther. 2024. PMID: 38762725 Free PMC article.
Poor accuracy and sustainability of the first-step FIB4 EASL pathway for stratifying steatotic liver disease risk in the general population.
De Vincentis A, Tavaglione F, Namba S, Kanai M, Okada Y, Kamatani Y, Maurotti S, Pedone C, Antonelli Incalzi R, Valenti L, Romeo S, Vespasiani-Gentilucci U. De Vincentis A, et al. Aliment Pharmacol Ther. 2024 Jun;59(11):1402-1412. doi: 10.1111/apt.17953. Epub 2024 Mar 18. Aliment Pharmacol Ther. 2024. PMID: 38497224
Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer's Disease.
Lantero-Rodriguez J, Salvadó G, Snellman A, Montoliu-Gaya L, Brum WS, Benedet AL, Mattsson-Carlgren N, Tideman P, Janelidze S, Palmqvist S, Stomrud E, Ashton NJ, Zetterberg H, Blennow K, Hansson O. Lantero-Rodriguez J, et al. Mol Neurodegener. 2024 Feb 17;19(1):19. doi: 10.1186/s13024-024-00707-x. Mol Neurodegener. 2024. PMID: 38365825 Free PMC article.
Fetal growth after fresh and frozen embryo transfer and natural conception: A population-based register study.
Ageheim M, Skalkidou A, Bergman E, Iliadis S, Lampa E, Lindström L, Oberg AS. Ageheim M, et al. BJOG. 2024 Feb 13. doi: 10.1111/1471-0528.17786. Online ahead of print. BJOG. 2024. PMID: 38351638
DESIGN: Longitudinal population-based cohort study. SETTING: Swedish national registers. POPULATION: A total of 196 008 singleton pregnancies between 2013 and 2017. METHODS: Of all singleton pregnancies resulting in live births in the Swedish Pregnancy Register, 10 …
DESIGN: Longitudinal population-based cohort study. SETTING: Swedish national registers. POPULATION: A total of 196 008 singleton pre …
A follow up on the feasibility after national implementation of magnesium sulfate for neuroprotection prior to preterm birth.
Hellström S, Jonsdotter A, Jonsson M, Pettersson K, Saltvedt S, Herbst A, Ågren J, Ådén U, Domellöf M, Hagberg H, Carlsson Y. Hellström S, et al. Acta Obstet Gynecol Scand. 2023 Dec;102(12):1741-1748. doi: 10.1111/aogs.14673. Epub 2023 Sep 8. Acta Obstet Gynecol Scand. 2023. PMID: 37680134 Free PMC article.
Prenatal administration of magnesium sulfate (MgSO(4) ) has been shown to be neuroprotective and reduces the proportion of very preterm born children later diagnosed with cerebral palsy. A Swedish national clinical practice guideline was implemented in March 2020, stipulat …
Prenatal administration of magnesium sulfate (MgSO(4) ) has been shown to be neuroprotective and reduces the proportion of very preterm born …
34 results